3TC

4-AMINO-1-[(2R,5S)-2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL]PYRIMIDIN-2(1H)-ONE

Created:2006-10-26
Last modified:  2020-06-05

Find related ligands:

Chemical Details

Formal Charge0
Atom Count26
Chiral Atom Count2
Bond Count27
Aromatic Bond Count6
2D diagram of 3TC

WebGL does not seem to be available.

This can be caused by an outdated browser, graphics card driver issue, or bad weather. Sometimes, just restarting the browser helps. Also, make sure hardware acceleration is enabled in your browser.

For a list of supported browsers, refer to http://caniuse.com/#feat=webgl.

Chemical Component Summary

Name4-AMINO-1-[(2R,5S)-2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL]PYRIMIDIN-2(1H)-ONE
Synonyms(-)-L-2',3'-DIDEOXY-3'-THIACYTIDINE; LAMIVUDINE; EPIVIR
Systematic Name (OpenEye OEToolkits)4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one
FormulaC8 H11 N3 O3 S
Molecular Weight229.256
TypeNON-POLYMER

Chemical Descriptors

TypeProgramVersionDescriptor
SMILESACDLabs10.04O=C1N=C(N)C=CN1C2OC(SC2)CO
SMILESCACTVS3.341NC1=NC(=O)N(C=C1)[CH]2CS[CH](CO)O2
SMILESOpenEye OEToolkits1.5.0C1C(OC(S1)CO)N2C=CC(=NC2=O)N
Canonical SMILESCACTVS3.341 NC1=NC(=O)N(C=C1)[C@@H]2CS[C@H](CO)O2
Canonical SMILESOpenEye OEToolkits1.5.0 C1[C@H](O[C@H](S1)CO)N2C=CC(=NC2=O)N
InChIInChI1.03 InChI=1S/C8H11N3O3S/c9-5-1-2-11(8(13)10-5)6-4-15-7(3-12)14-6/h1-2,6-7,12H,3-4H2,(H2,9,10,13)/t6-,7+/m0/s1
InChIKeyInChI1.03 JTEGQNOMFQHVDC-NKWVEPMBSA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
DrugBank IDDB00709 
NameLamivudine
Groups
  • approved
  • investigational
DescriptionA reverse transcriptase inhibitor and zalcitabine analog in which a sulfur atom replaces the 3' carbon of the pentose ring. It is used to treat Human Immunodeficiency Virus Type 1 (HIV-1) and hepatitis B (HBV).
Synonyms
  • beta-L-2',3'-Dideoxy-3'-thiacytidine
  • (-)-1-((2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine
  • Lamivudine
  • Lamivudin
  • 3TC
Brand Names
  • Apo-lamivudine Hbv
  • Jamp Lamivudine Hbv
  • PMS-abacavir-lamivudine
  • Symfi Lo
  • Epzicom
IndicationLamivudine is indicated in combination with other antiretrovirals the treatment of HIV infection and chronic hepatitis B (HBV).[L51474] In combination with [dolutegravir], lamivudine is indicated for the treatment of HIV-1 in patients ≥12 years of age and weighing ≥25 kg.[L51469]
Categories
  • Agents Causing Muscle Toxicity
  • Anti-HIV Agents
  • Anti-Infective Agents
  • Anti-Retroviral Agents
  • Antiinfectives for Systemic Use
ATC-Code
  • J05AR27
  • J05AR02
  • J05AR25
  • J05AR11
  • J05AR07
CAS number134678-17-4

Drug Targets

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
NameTarget SequencePharmacological ActionActions
Gag-Pol polyproteinMGARASVLSGGELDRWEKIRLRPGGKKKYKLKHIVWASRELERFAVNPGL...unknownmodulator
Reverse transcriptase/RNaseHPISPIETVPVKLKPGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKI...unknowninhibitor
DNA-unknownbinder
Protein PMPLSYPHFRKLLLLDDEAGPLEEELPRLADEDLNRRVAADLNLQLPNVSI...unknowninhibitor
Deoxycytidine kinaseMATPPKRSCPSFSASSEGTRIKKISIEGNIAAGKSTFVNILKQLCEDWEV...unknownsubstrate
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
PubChem 60825
ChEMBL CHEMBL141
ChEBI CHEBI:63577
CCDC/CSD QUWXOW, NUWKEX, RUKHAG01, WOMHEM, VISWAX, RUKHAG, COWTAK
COD 7215923